AcclaimIP-ad

Match Document Document Title
US20140056965 METHOD AND SYSTEM FOR TREATING DEPRESSION OR EPILEPSY  
A removable patch configured to be applied over a skin surface, comprises an adhesive layer disposed on the removable patch, and a delivery layer disposed on the removable patch. The delivery...
US20110256211 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
US20150017226 TOLTERODINE-CONTAINING ADHESIVE PATCH  
The present invention provides a tolterodine-containing patch in which an adhesive layer is laminated on a backing, characterized in that the adhesive layer is obtainable by adding tolterodine to...
US20150037395 TRANSDERMAL HORMONE DELIVERY SYSTEM: COMPOSITIONS AND MTEHODS  
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for control of fertility and as therapy for a variety of diseases and conditions treatable by robust delivery of...
US20140005617 FENTANYL TRANSDERMAL PATCH  
Provided is a fentanyl transdermal patch comprising an acrylic-rubber hybrid as a drug-adhesive layer. The fentanyl transdermal patch can maintain constant fentanyl skin permeability for three...
US20110150766 Transdermal patch with fatal overdose protection  
A transdermal patch having a top region containing an antagonist followed by a bottom region containing an agonist, whereby the bottommost end of the bottom region is secured to the skin of the...
US20110104246 METHOD OF WOUND TREATMENT USING LIQUID GALLIUM NITRATE  
A pharmaceutical composition and method for topical wound treatment by topical treatment with gallium salts, preferably gallium nitrate. In a preferred embodiment, the gallium nitrate is in an...
US20140294920 TRANSDERMAL PROPRANOLOL PATCH FOR TREATMENT OF MALIGNANT MELANOMA  
A transdermal d propranolol or racemic propranolol patch for use as an adjunct to surgery in the treatment of malignant melanoma and/or tattoo related applications are herein disclosed.
US20110150976 TRANSDERMAL DELIVERY OF OLIGOSACCHARIDES  
The present invention relates to a system for facilitating transdermal delivery of oligosaccharides, The system includes an apparatus that generates micro-channels in the skin of a subject and a...
US20110305746 PATCH FOR TREATING CONSTIPATION USING CRUDE DRUGS  
The present invention relates to a patch for treating constipation, which contains rhubarb ingredients selected from among crude drugs (medical herbs). More particularly, the present invention...
US20110313372 Transdermal administration of memantine  
The invention relates to transdermal therapeutic systems (TTS) which include, as active ingredient, the NMDA receptor antagonist memantine or one of its physiologically compatible salts. The TTSs...
US20140288481 TRANSDERMAL PATCH WITH NON-WATER SOLUBLE ADHESIVE AND ANESTHETIC  
Embodiments associated with a transdermal delivery device are described. In one embodiment, a transdermal delivery device comprises material coated on one surface with a mixture of a non-water...
US20140234396 EXTERNAL PATCHES CONTAINING ETOFENAMATE  
The present invention provides to patches having excellent skin-permeability and therapeutic effect by the drug with lower irritation. In an external patch in which an adhesive layer containing an...
US20110008413 Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome  
The present invention generally relates to transdermal drug delivery systems. More particularly, the present invention provides compositions and transdermal drug delivery systems for the treatment...
US20070298091 Transdermal Therapeutic System For Administering Analgesics  
Transdermal therapeutic systems for administering analgesics, preferably buprenorphine or one of its pharmaceutically acceptable salts or pro-drugs, and processes for the production of such systems.
US20050095278 Use of nitroglycerin to relieve nocturnal muscle cramps  
A method of treating nocturnal muscle cramps is provided. The method includes the step of administering to a patient with nocturnal muscle cramps an amount of nitroglycerin effective to relieve...
US20150104497 Topical Sphingosine-1-Phosphate Receptor Agonist Formulations and Methods of Using the Same  
Topical sphingosine-1-phosphate receptor agonist active agent formulations are provided. Aspects of the transdermal formulations include an amount of a sphingosine-1-phosphate receptor agonist...
US20140134230 TRANSDERMAL THERAPEUTIC SYSTEM  
The present invention relates to Transdermal Therapeutic Systems having a silicone adhesive layer, to Transdermal Therapeutic Systems providing specific plasma concentrations, to their manufacture...
US20070154534 Use of secretin in the treatment of schizophrenia  
The treatment of schizophrenia by administration of secretin to a patient in need thereof is disclosed.
US20110111013 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTRATION OF FENTANYL OR AN ANALOGUE THEREOF  
What is disclosed is a transdermal therapeutic system for administration of an active ingredient through the skin, comprising: (a) a back layer, (b) a reservoir present on the back layer,...
US20150231250 PATCH  
In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.
US20120171277 Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist  
A transdermal drug delivery patch has an excipient matrix containing an agonist for administration across the skin of a user, with the matrix further containing a plurality of spaced apart hollow...
US20140271798 Topical Copper Ion Treatments and Methods of Making Topical Copper Ion Treatments for Use in Various Anatomical Areas of the Body  
A topical copper ion treatment in basic form comprises a copper ion-containing solution composed of a biocompatible solution containing copper ions obtained by leaching of the copper ions from...
US20070224253 Transdermal Delivery of Meptazinol  
A delivery system for the delivery of a salt of meptazinol or meptazinol precursor which increases the bioavailability of meptanizol by an effective amount to provide analgesic relief is...
US20100021529 STEP-DOWN ESTROGEN REGIMEN FOR WOMEN RECEIVING ESTROGEN THERAPY  
The present invention relates to methods for continuous treatment of diseases, conditions and/or symptoms associated with deficient endogenous levels of estrogen in a woman already receiving a...
US20110223237 SELEGILINE-CONTAINING ADHESIVE PREPARATION  
The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive...
US20120064146 Wound care device  
A wound care device for local treatment of pain in a wound, said device comprising an active pain relieving composition, the device being constructed in such a manner that the pain killing agent...
US20070196460 External preparation for treating skin or mucosal injury caused by viral infection  
An external preparation containing acetylsalicylic acid or a pharmacologically acceptable salt thereof as an active ingredient, which is used for treatment of vesicle, sore or ulcer of skin or...
US20140170208 TRANSDERMAL PATCH FORMULATION  
A method for preparing a transdermal patch comprising a substrate layer is provided, the method comprising the steps of contacting an active pharmaceutical ingredient with a retaining means to...
US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic  
An external preparation for percutaneous administration which contains a light-sensitive nonsteroidal anti-inflammatory analgesic and a UVA-shielding agent which inhibits the analgesic to cause...
US20140105959 METHOD AND DEVICE FOR REDUCING DERMAL FILLER ADVERSE EVENTS  
Methods and devices of aesthetically enhancing and improving appearance of aging skin are provided. Methods may include the steps of treating a skin site selected for dermal filler administration...
US20090130190 Transdermal System for the Delivery of Sufentanil and Its Analogs  
Methods and systems for the transdermal delivery of sufentanil and its analogs are described, from patches having a unique pharmacodynamic profile that can be used to treat persistent pain over...
US20110182972 LOW-CONCENTRATION CAPSAICIN PATCH AND METHODS FOR TREATING NEUROPATHIC PAIN  
Described here are patches and methods for treating neuropathic pain. In some variations, the neuropathic pain-relieving patch comprises capsaicin or a capsaicin analog, wherein the concentration...
US20100028413 SKIN TREATMENT STRIP  
The skin treatment strip includes a base liner and an applicant liner coupled to the base liner by an adhesive. The skin treatment strip further includes a chemical layer sandwiched between the...
US20070077284 Transdermal formulation comprising an opioid analgesic and an aloe composition  
The invention concerns a formulation comprising an apioid analgesic from the phenanthrene group or a pharmaceutically acceptable salt thereof as active ingredient and an aloe composition as...
US20140370078 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds  
Compositions and methods are provided for the prevention and treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent...
US20110004150 Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat  
A method for delivery of substance through at least one dermal layer, by providing a substance in microcapsules at a predetermined size, within a medium (150) for holding the microcapsules;...
US20150104499 TRANSDERMAL PATCH AND METHOD FOR DELIVERY OF VITAMIN B12  
The present invention is directed to compositions and devices for transdermally administering vitamin B12 to a subject. In one aspect, a vitamin B12 containing composition suitable for transdermal...
US20060029654 Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain  
The present invention relates to a method for topical treatment of pain resulting from a sports injury, including injuries to bones and soft tissue, such as ligaments, muscles or tendons. The...
US20120034293 TRANSDERMAL DELIVERY OF CANNABINOIDS  
The present invention overcomes the problems associated with existing drug delivery systems by delivering cannabinoids transdermally. Preferably, the cannabinoids are delivered via an occlusive...
US20130331803 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHINE  
The invention is concerned with a transdermal therapeutic system (TTS) comprising buprenorphine and a method of manufacturing such a TTS. The transdermal therapeutic system is used for the...
US20150064232 TRANSDERMAL ABSORPTION PREPARATION  
[Problem] To provide a transdermal absorption preparation exhibiting excellent transdermal absorbability for 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide or a pharmaceutically acceptable salt...
US20150258037 TRANSDERMAL DOSAGE FORM FOR LOW-MELTING POINT ACTIVE AGENT  
A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A...
US20140188057 TRANSDERMAL DOSAGE FORM FOR LOW-MELTING POINT ACTIVE AGENT  
A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A...
US20140100537 TRANSDERMAL PHARMACEUTICAL PREPARATION AND ADMINISTRATION OF TIROFIBAN  
The present invention provides a titratable transdermal drug delivery system comprising an effective dose of an antithrombotic agent, such as tirofiban, or a pharmaceutically acceptable salt...
US20050118245 Assembled unit consisting of individually separable, transdermal, therapeutic systems  
The invention relates to an assembled unit consisting of individually separable transdermal therapeutic systems.
US20140220104 PATCH CONTAINING RIVASTIGMINE  
The present invention relates to a rivastigmine-containing patch having improved storage stability and proper release property.
US20080279915 Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen  
The invention relates to a transdermal therapeutic system comprising an active-ingredient-impermeable top layer, an active-ingredient-containing matrix and a removable protective layer, the matrix...
US20050169976 Insulin administration apparatus  
The present invention provides an insulin-administering device enabling the effective administration of insulin via a percutaneous or submucous administration route. The present device is used to...
US20100055161 HYDROGEL FACE MASK FOR DELIVERING SKIN CARE AGENTS  
Skin care can be provided by the skin care devices and compositions described herein. Such a skin care device can be configured to include a biocompatible hydrogel layer including one or more...